Full Answer
Diagnosis Code for Reimbursement Claim: ICD-9-CM 287.5. Code will be replaced by October 2015 and relabeled as ICD-10-CM 287.5. The Short Description Is: Thrombocytopenia NOS.
ICD-9-CM 287.5 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 287.5 should only be used for claims with a date of service on or before September 30, 2015.
Thrombocytopenia, unspecified. A condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues. A condition in which there is an abnormally small number of platelets in the circulating blood. A decrease in...
A subnormal level of blood platelets. Decrease in the number of blood platelets. ICD-10-CM D69.6 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 813 Coagulation disorders
Other secondary thrombocytopenia The 2022 edition of ICD-10-CM D69. 59 became effective on October 1, 2021. This is the American ICD-10-CM version of D69. 59 - other international versions of ICD-10 D69.
ICD-10 code D69. 5 for Secondary thrombocytopenia is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
reactive thrombocytosis (D75.838)secondary thrombocytosis (D75.838)thrombocythemia NOS (D75.839)thrombocytosis NOS (D75.839)
ICD-10-CM Code for Thrombocytopenia, unspecified D69. 6.
Chemotherapy-induced thrombocytopenia (CIT) is a potentially serious complication that can lead to chemotherapy dose delays, dose reductions, or discontinuation, and increases the risk of serious bleeding events.
Secondary ITP is known to be caused by systemic autoimmune disorders, primary or secondary immunodeficiency, infectious diseases, paraneoplastic syndromes (e.g., lymphomas and other malignancies), and drug-dependent antibodies (5).
Secondary thrombocytosis, also known as reactive thrombocytosis defined as an abnormally high platelet count due to underlying events, disease, or the use of certain medications.
Primary thrombocytosis is a myeloproliferative disease, caused by monoclonal or polyclonal abnormalities of haematopoietic cells or by abnormalities in the biology of Tpo. Secondary thrombocytosis is caused by stimulated megakaryopoiesis because of various haematological or non-haematological disorders.
Thrombocythemia refers to a high platelet count that is not caused by another health condition. This condition is sometimes called primary or essential thrombocythemia. Thrombocytosis refers to a high platelet count caused by another disease or condition.
Z86. 2 - Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | ICD-10-CM.
Thrombocytopenia, unspecified D69. 6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D69. 6 became effective on October 1, 2021.
Thrombocytopenia is a condition in which you have a low blood platelet count. Platelets (thrombocytes) are colorless blood cells that help blood clot. Platelets stop bleeding by clumping and forming plugs in blood vessel injuries.
198.7 Metastasis to adrenal gland 198.5 Metastasis to bone and/or marrow 198.3 Metastasis to brain and/or spinal cord 197.7 Metastasis to liver 197.0 Metastasis to lung 196.9 Metastasis to lymph nodes NOS 198.4 Metastasis to meninges (carcinomatous meningitis) 197.3 Metastasis to pleura (malignant effusion) 197.6 Metastasis to retro/peritoneum
Note that billing codes with a * are not billable without the extra digit, which usually specifies anatomic distribution in the case of lymphoma.
V42.81 Bone marrow replaced by transplant (post-transplant) 996.85 Complications bone marrow transplant (e.g graft vs. host) V59.3 Donor, bone marrow V59.02 Donor, blood stem cells V42.82 Peripheral stem cells replaced by transplant (post-transplant)
Clinical Information. A condition in which there is a lower-than-normal number of platelets in the blood. It may result in easy bruising and excessive bleeding from wounds or bleeding in mucous membranes and other tissues.
A decrease in the number of platelets in the blood that may result in easy bruising and excessive bleeding from wound s or bleeding in mucous membranes and other tissues. A finding based on laboratory test results that indicate a decrease in number of platelets in a blood specimen. A subnormal level of blood platelets.